Ablation of STING in CAR-T Cells Enhances Efficacy with STING Agonist in Pancreatic Cancer Thera

Ablating the immune sensor STING in CAR-T cells enhances their effectiveness against pancreatic cancer when combined with a STING-activating drug that boosts immune responses in the tumor environment.